TrialNeurology2020
Efficacy and safety of eptinezumab in patients with chronic migraine: PROMISE-2.
Richard B Lipton et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
193 papers cite itlatest 60 shown
this paperpooled ittrialcites it